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Abstract Previous studies of follicular thyroid tumors
have shown loss of heterozygosity (LOH) on the short
arm of chromosome 3 in carcinomas, and on chromosome
10 in atypical adenomas and carcinomas, but not in com-
mon adenomas. We studied LOH on these chromosomal
arms in 15 follicular thyroid carcinomas, 19 atypical fol-
licular adenomas and 6 anaplastic (undifferentiated) carci-
nomas. Deletion mapping of chromosome 10 using 15
polymorphic markers showed that 15 (37.5%) of the tu-
mors displayed LOH somewhere along the long arm.
Thirteen of these tumors showed deletions involving the
telomeric part of chromosome lOq, distal to D10S187.
LOH on chromosome 3p was found in 8 (20%) cases.
Seven of these also showed LOH on chromosome lOq. In
eight cases LOH was seen on chromosome lOq but not
3p. In comparison, the retinoblastoma gene locus at chro-
mosome 13q showed LOH in 22% of the tumors. Most of
these also had deletions on chromosome lOq. The results
indicate that a region at the telomeric part of 1 Oq may be
involved in progression of follicular thyroid tumors.
Introduction
Follicular thyroid tumors serve as a good model for study-
ing possible genetic events in tumor progression. Some
steps have been elucidated, and schemes for multi-stage
tumorigenesis have been proposed (Fagin 1992; Wynford-
Thomas 1993; Farid et al. 1994). A recent study of allelo-
types of follicular thyroid tumors has allowed us to sug-
gest the addition of genetic loss of the long arm of chro-
mosome 10 in atypical follicular adenomas and follicular
carcinomas to these schemes (Zedenius et al. 1995a).
Follicular thyroid tumors consist of common (trabecu-
lar/solid, microfollicular, normofollicular, macrofollicular)
adenomas, Hiirthle (oxyphil cell) adenomas, atypical ade-
nomas (including oxyphil cell type), and carcinomas
(Hedinger et al. 1988). The latter group may be further sub-
divided into minimally and widely invasive carcinomas,
mainly depending on their local growth pattern (Hedinger
et al. 1988). Furthermore, there is evidence that differenti-
ated thyroid carcinomas transform to poorly differentiated
and anaplastic carcinoma types (Ito et al. 1992; Hadar et al.
1993; van der Laan et al. 1993; Dobashi et al. 1994).
The aim of this study was to investigate the signifi-
cance of chromosome 10 deletions in follicular tumors of
the thyroid gland. The results verify that genetic loss on




The study included thyroid tumor samples from 40 patients: 6
anaplastic carcinomas, 15 follicular carcinomas (6 of which were
classified as Hiirthle carcinomas), and 19 atypical follicular adeno-
mas (5 of which were Hiirthle type). The histopathological classi-
fication was as suggested by the WHO committee (Hedinger et al.
1988), and is given for each tumor in Table 1.
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DNA preparation
High molecular weight DNA was obtained from the snap-frozen
tumor tissues by phenol-chloroform extraction and ethanol precip-
itation according to standard methods. To prove the representa-
tiveness of the tumor material, pieces were cut from all specimens
for histopathological examination. All tumor samples contained
more than 60% tumor cells.
The patients leukocytes (26/40) or normal thyroid tissue
(14/40) were used for extraction of constitutional DNA. Thus, the




Detection of loss of heterozygosity (LOH) Table 1 Histopathological classification and summary of the loss
of heterozygosity (LOH) analysis results of each of the 40 tu-
Two techniques were used for the deletion study: Southern blot hy-
able number of tandem repeats (RFLP/VNTR) markers, and the
repeat polymorphisms (i.e., CA repeats).
Three polymorphic markers localized to chromosome lOq were
used for Southern hybridization: DIOSl/Dry 5-1, D10S4/pl-101,
and D10S25/Efd 75 (NIH/CEPH Collaborative Mapping Group
1992). High molecular weight DNA was digested with Taq\, sep-
arated on agarose gels, and transferred to Zeta-Probe nylon filters
(Bio-Rad), which were hybridized and autoradiographed as de-
scribed (Zedenius et al. 1995a). LOH was detected as either a total
absence of signal, or > 50% reduced signal intensity of one of the
constitutional alleles in the DNA of the thyroid tumor tissue.
Twelve microsatellite markers located on chromosome 10 were
used for the deletion mapping: D10S249/AFM207wdl2, D10S21 1/
AFM198wf8, D10S193/AFM095zh7, D10S141, ZNF22, D10S215/
AFM205wdl2, D10S205/AFM164yd8, DIOS187/AFM042xa9,
D10S190/AFM065yhll, D10S216/AFM205zd8, D10S217/
AFM212xd6, and D10S555/AFM242yc7 (Gyapay et al. 1994; Love
et al. 1993a,b). In addition, one marker on chromosome Ipter
(DlS243/AFM214yg7), four located on chromosome 3p25-14
(D3S656, D3S1029, D3S1076, D3S1217/MIT-F8), and one on
chromosome 13q (Rb 1.20) were analyzed (NIH/CEPH Collabora-
tive Mapping Group 1992, Gyapay et al. 1994; Jones et al. 1992;
Yandell and Dryja 1989). All chromosome 10 markers, their rela-
tive order and approximate chromosomal locations are given in
Fig. 1. PCR reactions were carried out in a final volume of 10 \i\,
containing 40 ng of high molecular weight DNA, 50 mM KC1, 10
mM Tris-HCI, pH 8.3, 1.5 mM MgCl,, 125 fiW of each dNTP, 2
pmol of each oligodeoxynucleotide primer (one of which was end-
labeled with 32P), and 0.2 U DNA polymerase (Dynazyme,
Finnzyme Oy). The standard thermal cycling conditions were: in-
cubation at 94° C for 4 min, 25 step cycles at 94° C for 1 min, 60°
C for 1 min and at 72° C for 1 min with a final extension for 7 min
at 72° C. Aliquots of the PCR product were denatured with for-
mamide, heated and electrophoresed on denaturing polyacry-
lamide gels, which were fixed, dried, and subjected to autoradiog-
raphy. LOH was detected as described above.
Results
We investigated 40 thyroid tumors for LOH on five diro-
mosomal arms using 21 polymorphic markers. The histo-
pathological diagnoses and a summary of the LOH data
for each tumor is given in Table 1 . Fifteen of the 40 tu-
mors (37.5%) showed LOH somewhere on the long arm,
while 8 (20%) showed LOH on the short arm of chromo-
some 10. LOH at chromosome lp was found in 5 of 36
(14%) informative cases. Four markers on chromosome
3p together showed LOH in 8 of the 40 tumors (20%). In
7 of these all informative markers on 3p showed LOH, in-
dicating loss of the whole chromosomal arm. In only 1
case (no. 20), was LOH found at chromosome 3p but not
lOq, while in 8 cases, LOH was seen on chromosome lOq
but not 3p. LOH of the retinoblastoma gene locus (Rb
1.20) at chromosome 13q was seen in 7 of 32 (22%) in-
formative cases; again few of these (nos. 3 and 37) did not
show LOH at chromosome 10.
Fifteen polymorphic markers were used for deletion
mapping of chromosome 10 (Figs. 1 and 2). This revealed
that six of the tumors seemed to have lost the entire chro-
mosome (nos. 18, 24, 25, 29, 31, and 33). Five of these
were atypical adenomas, and one was a minimally inva-
mors
Tumor Histopathological LOH data6 for chromosome
lp 3p 10p lOq 13q
1 ATC, no diff. + + + + +
2 ATC, no diff. + + + +
3 ATC, PTC diff. + + + + LOH
4 ATC, PTC diff. + + + + +
5 ATC, foil diff. + LOH LOH LOH LOH
6 ATC, foil diff. + LOH + LOH +
7 FTC, WI + LOH + LOH LOH
8 FTC, WI LOH + + LOH +
9 FTC, WI + + + + +
10 FTC, insular, WI + + + +
1 1 FTC. MI + + + + +
12 FTC, MI + + + NA
13 FTC, MI + + + + +
14 FTC, MI + + + + +
15 FTC, MI + + + + +
16 HTC, WI + + + + +
17 HTC, WI LOH + + +
18 HTC, MI LOH LOH LOH NA
19 HTC, MI + + + LOH NA
20 HTC, MI + LOH + + +
21 HTC, MI + + + LOH +
22 AFA + + + + +
23 AFA + + + + +
24 AFA + + LOH LOH +
25 AFA LOH LOH LOH LOH
26 AFA . + + + +
27 AFA + + + + +
28 AFA + + + + +
29 AFA LOH LOH LOH LOH LOH
30 AFA + + + + +
31 AFA + + LOH LOH LOH
32 AFA + + + +
33 AFA LOH LOH LOH LOH LOH
34 AFA + + + + +
35 AFA + + + + +
36 AHA + + + LOH +
37 AHA + + + + LOH
38 AHA + + LOH LOH
39 AHA + + + LOH +
40 AHA + + + + +
" Histopathological diagnosis according to the classification by the
WHO committee (Hedinger et al. 1988). Within each diagnostic
group, the patients are listed consecutively. ATC anaplastic thyroid
carcinoma, FTC follicular thyroid carcinoma, HTC Hiirthle carci-
noma, AFA atypical follicular thyroid adenoma, AHA atypical
Hiirthle adenoma, PTC diff puns within the specimen with papillary
thyroid carcinoma differentiation, foil diff parts within the specimen
with follicular structures, WI widely invasive, Ml minimally inva-
sive
h Accumulated results from the LOH analysis. + retained heterozy-
gosity, - not informative, LOH loss of one of the constitutional alle-
les in the tumor DNA (at chromosome 3p and 10 as shown with at
least one of the markers used), NA not analyzed
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Fig. 1 Tumors in this study
showing LOH on chromosome
10, The 15 markers used for
the deletion mapping are given
to the right of an ideogram of
the chromosome. The relative
order of the markers is accord-
ing to the GDB Map C10M50
and the NIH/CEPH Collabora-
tive Mapping Group (1992).
The physical location of the
markers on the chromosome is
approximate. Tumor numbers
refer to Table 1. Empty circles
symbolize retained heterozy-
gosity, gray circles homozy-
gous alleles (i.e., marker not
informative for the locus), and
black circles LOH. The dashed
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Fig. 2 Autoradiograms showing LOH on chromosomes lOq (mar-
kers ZNF22, D10S4 and D10S216) and 3p (marker D3S1217),
and retention of heterozygosity on chromosome l()p (marker
D10S211 ) in the follicular thyroid carcinoma from patient number 7.
The markers used are given at the top of each autoradiogram, and
the lost allele is indicated by an arrow. C constitutional DNA, T
tumor DNA
sive Hürthle carcinoma. Thirteen of the 15 tumors with
LOH on lOq showed deletions involving the distal part of
the chromosomal arm (telomeric of D l OS 187). However, a
single minimal region of overlapping deletions could not be
identified; for example, tumor 6 showed retained heterozy-
gosity at D10S217, but losses at both centromeric and
telomeric loci. In addition, four tumors (no. 8, 36, 38 and
39) had deletions toward the centromere. Altogether, three
putative minimal regions of overlapping deletions may be
identified: D10S187-D10S216 and D10S217-D10S25 in
the telomeric part, and D10S141-ZNF22 at the centromere.
In contrast to other tumor types (Thibodeau et al. 1993),
microsatellite instability was not seen in any tumor.
Discussion
In several tumor types, detection of genetic loss by study-
ing LOH has been a useful method to localize putative tu-
mor suppressor genes and indicate genetic events in-
Ü
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volved in tumor progression (Zedenius et al. 1995b). For-
mer studies of thyroid tumors have implicated LOH at
chromosome I l q l 3 in follicular adenomas (Matsuo et al.
1991), at chromosome 3p in follicular carcinomas (Herr-
mann et al. 1991; Roque et al. 1993), and at chromosome
lOq in atypical adenomas and carcinomas (Zedenius et al.
1995a). However, the number of carcinomas was small in
the latter study. To investigate further the frequency of 3p
and lOq deletions in malignant follicular thyroid tumors
and their putative impact on tumor progression, we stud-
ied LOH in several atypical adenomas, follicular carcino-
mas, and anaplastic carcinomas.
In the study of Herrmann et al. (1991), all six carcinomas
investigated showed deletions of chromosome 3p, mainly
involving large parts of the arm. We used four markers at
chromosome 3p25-14. LOH was found in 20% of the tu-
mors, but only a single tumor showed LOH at this location
and not on chromosome lOq, which is in contrast to earlier
reports (Jenkins et al. 1990; Herrmann et al. 1991; Roque et
al. 1993). Although small interstitial deletions cannot be ex-
cluded, we conclude that LOH on 3p is probably not a pre-
requisite for development of follicular thyroid carcinomas.
We also investigated chromosome lp for LOH owing
to the fact that in the former allelotype study, two of three
carcinomas showed LOH at this location. In the present
study, 14% of the tumors showed LOH at Ipter, probably
not exceeding the level of "background" LOH.
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LOH at the retinoblastoma locus on chromosome 13q
was higher, 22%, as compared with the number in our for-
mer study (Zedenius et al. 1995a). A recent report has
suggested the involvement of this gene in 55% of follicu-
lar thyroid carcinomas, but not in adenomas (Zou et al.
1994). The same has been shown for parathyroid tumors,
where only carcinomas showed LOH at this locus (Cryns
et al. 1994). Our results do not strongly support the in-
volvement of this gene in follicular thyroid tumors, but in-
dicate that a subset of tumors may delete this gene during
their development. Notable is the deletion in one of the
anaplastic carcinomas (no. 3), which was the only dele-
tion found for this tumor.
Despite the fact that the overall LOH frequency was
fairly low in our earlier allelotype study, some LOH pat-
terns were discernible (Zedenius et al. 1995a). The major-
ity of tumors with atypical features (i.e., atypical adeno-
mas and carcinomas), but none of 58 common adenomas,
showed LOH on lOq. In the present material, the overall
frequency of LOH at lOq was 37.5%. Six tumors, five of
which were atypical adenomas, showed LOH on the en-
tire chromosome. In contrast, in follicular carcinomas the
deletions were more restricted to 1 Oq (Table 1, Figs. 1 and
2).
In addition, two of the anaplastic carcinomas showed
LOH at lOq (nos. 5 and 6). These were the only anaplas-
tic tumors displaying histopathological patterns resem-
bling a follicular differentiation within or close to the un-
differentiated tumor. The two anaplastic tumors with pap-
illary carcinoma structure adjacent to the anaplastic carci-
noma (nos. 3 and 4) did not show LOH on lOq. It cannot
be proven that these four anaplastic tumors emerged as a
result of de-differentiation of the differentiated counter-
parts, but the difference in LOH pattern may favor the hy-
pothesis of a tumor suppressor involved specifically in
progression of follicular thyroid tumors.
LOH on the long arm of chromosome 10 has also been
found in the progression of other tumor types, e.g.,
glioblastomas (Leon et al. 1994), malignant meningiomas
(Rempel et al. 1993), malignant melanomas (Isshiki et al.
1993), and bladder carcinomas (Wang et al. 1994). In an
earlier paper, we touched upon an interesting finding of an
aggressive follicular thyroid carcinoma in a young girl
with a constitutional ring chromosome, most likely lack-
ing genetic material at the distal part of chromosome lOq
(Sparkes et al. 1978; Tommerup and Lothe 1992). In the
present study, more than one-third of the tumors showed
LOH at chromosome lOq (Fig 1). All but two of these had
deletions involving regions distal to D l OS 187. This com-
parably frequent finding in tumors with atypical or malig-
nant features indicates a tumor suppressor gene in this re-
gion that is involved in progression of follicular thyroid
tumors.
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